Literature DB >> 811432

Anisodamine in treatment of some diseases with manifestations of acute microcirculatory insufficiency.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 811432

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN： 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  6 in total

1.  [Dopaminergic effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats].

Authors:  A P Zou; N Parekh; M Steinhausen
Journal:  J Tongji Med Univ       Date:  1991

2.  Enteric administration of anisodamine in the treatment of hemorrhagic shock.

Authors:  J Y Su; C E Hock; A M Lefer
Journal:  Acta Acad Med Wuhan       Date:  1985

3.  Beneficial effect of anisodamine in hemorrhagic shock.

Authors:  J Su; C E Hock; A M Lefer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

4.  Effectiveness of anisodamine for the treatment of critically ill patients with septic shock (ACIdoSIS study): study protocol for randomized controlled trial.

Authors:  Zhongheng Zhang; Jiancang Zhou; You Shang; Xin'an Wang; Rui Yin; Zhenhua Zhu; Wensen Chen; Xin Tian; Yuetian Yu; Xiangrong Zuo; Kun Chen; Xuqing Ji; Hongying Ni
Journal:  Ann Transl Med       Date:  2015-10

5.  Beneficial effects of anisodamine in shock involved cholinergic anti-inflammatory pathway.

Authors:  Ting Zhao; Dong-Jie Li; Chong Liu; Ding-Feng Su; Fu-Ming Shen
Journal:  Front Pharmacol       Date:  2011-05-02       Impact factor: 5.810

6.  Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19.

Authors:  Zhen Qin; Kefa Xiang; Ding-Feng Su; Yang Sun; Xia Liu
Journal:  Front Immunol       Date:  2021-02-08       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.